Trump slaps 100pc tariffs on Australian drugs – with exceptions

3 April 2026 - Australian drug makers that do not build new factories in America and dramatically cut their prices ...

Read more →

Trump puts Australia’s drugs scheme, digital rules in firing line

1 April 2026 - Donald Trump’s top trade tsar claims Australia’s unfair drug pricing practices are undermining US innovation, warns ...

Read more →

Cheaper medicines for people fighting cancer and rare diseases

1 April 2026 - The Albanese Government is continuing to deliver cheaper medicines with Australians living with debilitating conditions including ...

Read more →

Schedule of Pharmaceutical Benefits - 1 April 2026

1 April 2026 - The April 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Leading cancer drug subsidised for thousands of patients

29 March 2026 - Health Minister Mark Butler has expanded the PBS listing of a leading cancer drug, giving more than ...

Read more →

Expanded immunotherapy PBS listing to treat more cancers

29 March 2026 - The Albanese Government is continuing to deliver cheaper medicines with thousands more Australians living with advanced ...

Read more →

Agenda for the July 2026 PBAC meeting (25 March 2026)

25 March 2026 - The agenda for the July 2026 PBAC meeting is now available.  ...

Read more →

Public summary documents (first time decisions not to recommend and deferrals) – November 2025 PBAC meeting

20 March 2026 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2025 PBAC ...

Read more →

PBAC advice on equitable access to GLP-1 obesity treatments

17 March 2026 - On 6 March 2025, Minister Butler wrote to the PBAC to request the Committee’s advice on ...

Read more →

The end of cancer: how cell therapy breakthroughs have us on the edge of a cure

15 March 2026 - How rapid immunotherapy advancements could relegate killer cancers to the status of a ‘chronic disease’. ...

Read more →

Cutting-edge cancer treatment research heading offshore as local patients miss out

11 March 2026 - Newsreader Will McDonald is six years into his fight with aggressive prostate cancer. He wants all Australians ...

Read more →

New multi-indication PBS listing for two immunotherapy treatments from March 2026

1 March 2026 - Bristol Myers Squibb Australia confirms that Opdivo (nivolumab) and Yervoy (ipilimumab) will be listed on the ...

Read more →

Dying father pleads for cancer drug subsidy to ‘keep being a dad’

5 March 2026 - A North Queensland mother has travelled to Canberra to beg the Federal Government to save her ...

Read more →

World first cheaper immunotherapy treatment listing for patients with advanced or rare cancers

1 March 2026 - From today, thousands more Australians living with advanced and rare cancers will have access to affordable ...

Read more →

More cheaper medicines to help Australians fight complex and chronic illness

2 March 2026 - Australians living with auto-immune disease, lymphoma, Parkinson's, motor neuron disease and cerebral palsy will have access ...

Read more →